Publications
204 results found
Pal S, Myburgh J, Bansil P, et al., 2021, Reference and point-of-care testing for G6PD deficiency: Blood disorder interference, contrived specimens, and fingerstick equivalence and precision, PLOS ONE, Vol: 16, ISSN: 1932-6203
- Author Web Link
- Cite
- Citations: 6
Al-Samkari H, Galacteros F, Glenthoj A, et al., 2021, ACTIVATE: A phase 3, randomized, multicenter, double-blind, placebo-controlled study of mitapivat in adults with Pyruvate kinase deficiency who are not regularly transfused, Publisher: KARGER, Pages: 40-40, ISSN: 2296-5270
Al-Samkari H, Grace RF, Glenthoj A, et al., 2021, Early-Onset osteopenia and osteoporosis in patients with pyruvate kinase deficiency, Publisher: KARGER, Pages: 170-170, ISSN: 2296-5270
Al-Samkari H, Grace RF, Glenthoej A, et al., 2020, Early-Onset Osteopenia and Osteoporosis in Patients with Pyruvate Kinase Deficiency, 62nd Annual Meeting of the American-Society-of-Hematology (ASH), Publisher: AMER SOC HEMATOLOGY, ISSN: 0006-4971
- Author Web Link
- Cite
- Citations: 3
Grace RF, Boscoe A, Bowden C, et al., 2020, Baseline Characteristics of Patients in Peak: A Global, Longitudinal Registry of Patients with Pyruvate Kinase Deficiency, 62nd Annual Meeting of the American-Society-of-Hematology (ASH), Publisher: AMER SOC HEMATOLOGY, ISSN: 0006-4971
Layton D, Piel F, Telfer P, 2020, Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patients, Haematologica: the hematology journal, Vol: 105, Pages: 2651-2654, ISSN: 0390-6078
Roy NBA, Telfer P, Eleftheriou P, et al., 2020, Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic, British Journal of Haematology, Vol: 189, Pages: 635-639, ISSN: 0007-1048
With the developing COVID‐19 pandemic, patients with inherited anaemias require specific advice regarding isolation and changes to usual treatment schedules. The National Haemoglobinopathy Panel (NHP) has issued guidance on the care of patients with sickle cell disease, thalassaemia, Diamond Blackfan anaemia (DBA), congenital dyserythropoietic anaemia (CDA), sideroblastic anaemia, pyruvate kinase deficiency and other red cell enzyme and membrane disorders. Cascading of accurate information for clinicians and patients is paramount to preventing adverse outcomes, such as patients who are at increased risk of fulminant bacterial infection due to their condition or its treatment erroneously self‐isolating if their fever is mistakenly attributed to a viral cause, delaying potentially life‐saving antibiotic therapy. Outpatient visits should be minimised for most patients, however some, such as first transcranial dopplers for children with sickle cell anaemia should not be delayed as known risk of stroke will outweigh the unknown risk from COVID‐19 infection. Blood transfusion programmes should be continued, but specific changes to usual clinical pathways can be instituted to reduce risk of patient exposure to COVID‐19, as well as contingency planning for possible reductions in blood available for transfusions. Bone marrow transplants for these disorders should be postponed until further notice. With the current lack of evidence on the risk and complications of COVID‐19 infection in these patients, national data collection is ongoing to record outcomes and eventually to identify predictors of disease severity, particularly important if further waves of infection travel through the population.
Roper D, Layton M, Rees D, et al., 2020, Laboratory diagnosis of G6PD deficiency. A British Society for Haematology Guideline, BRITISH JOURNAL OF HAEMATOLOGY, Vol: 189, Pages: 24-38, ISSN: 0007-1048
- Author Web Link
- Cite
- Citations: 21
Hui YMT, Gurung K, Mkandawire C, et al., 2020, Audit of red cell genotyping in sickle cell disease patients in two London trusts, 60th Annual Scientific Meeting of the British-Society-for-Haematology (BSH), Publisher: WILEY, Pages: 175-175, ISSN: 0007-1048
Rio-Machin A, Vulliamy T, Hug N, et al., 2020, The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants, Nature Communications, Vol: 11, Pages: 1-12, ISSN: 2041-1723
The inclusion of familial myeloid malignancies as a separate disease entity in the revised WHO classification has renewed efforts to improve the recognition and management of this group of at risk individuals. Here we report a cohort of 86 acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) families with 49 harboring germline variants in 16 previously defined loci (57%). Whole exome sequencing in a further 37 uncharacterized families (43%) allowed us to rationalize 65 new candidate loci, including genes mutated in rare hematological syndromes (ADA, GP6, IL17RA, PRF1 and SEC23B), reported in prior MDS/AML or inherited bone marrow failure series (DNAH9, NAPRT1 and SH2B3) or variants at novel loci (DHX34) that appear specific to inherited forms of myeloid malignancies. Altogether, our series of MDS/AML families offer novel insights into the etiology of myeloid malignancies and provide a framework to prioritize variants for inclusion into routine diagnostics and patient management.
Layton DM, Okoli S, 2020, Hemoglobinopathies due to structural mutations, MOLECULAR HEMATOLOGY, 4TH EDITION, Editors: Provan, Gribben, Publisher: WILEY-BLACKWELL, Pages: 173-191, ISBN: 978-1-11-925287-0
Grace RF, Bianchi P, Glader B, et al., 2019, An Ongoing Global, Longitudinal, Observational Study of Patients with Pyruvate Kinase Deficiency: The PEAK Registry, 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Publisher: AMER SOC HEMATOLOGY, ISSN: 0006-4971
- Author Web Link
- Cite
- Citations: 1
Kuo KHM, Layton DM, Uhlig K, et al., 2019, Mitapivat (AG-348), an Oral PK-R Activator, in Adults with Non-Transfusion Dependent Thalassemia: A Phase 2, Open-Label, Multicenter Study in Progress, 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Publisher: AMER SOC HEMATOLOGY, ISSN: 0006-4971
- Author Web Link
- Cite
- Citations: 1
Grace RF, Layton DM, Galacteros F, et al., 2019, Long-Term Safety and Efficacy of Mitapivat (AG-348), a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency: The DRIVE PK Study, 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Publisher: AMER SOC HEMATOLOGY, ISSN: 0006-4971
- Author Web Link
- Cite
- Citations: 2
Grace RF, Rose C, Layton DM, et al., 2019, Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency, NEW ENGLAND JOURNAL OF MEDICINE, Vol: 381, Pages: 933-944, ISSN: 0028-4793
- Author Web Link
- Cite
- Citations: 84
Shabbir S, Al-Abdulla A, Kinderlerer A, et al., 2019, OFF-LICENCE USE OF ANAKINRA IN CRITICALLY ILL ADULTS WITH SUSPECTED HAEMOPHAGOCYTOSIS - A SINGLE CENTRE EXPERIENCE, Annual European Congress of Rheumatology (EULAR), Publisher: BMJ PUBLISHING GROUP, Pages: 292-293, ISSN: 0003-4967
- Author Web Link
- Cite
- Citations: 2
Bianchi P, Glader B, Grace R, et al., 2019, PEAK REGISTRY: A GLOBAL LONGITUDINAL OBSERVATIONAL STUDY OF PATIENTS WITH PYRUVATE KINASE DEFICIENCY, Publisher: WILEY, ISSN: 1545-5009
Grace RF, Layton DM, Barcellini W, 2019, How we manage patients with pyruvate kinase deficiency (vol 184, pg 721, 2019), BRITISH JOURNAL OF HAEMATOLOGY, Vol: 185, Pages: 807-807, ISSN: 0007-1048
Howard J, Hemmaway CJ, Telfer P, et al., 2019, A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease, BLOOD, Vol: 133, Pages: 1865-1875, ISSN: 0006-4971
- Author Web Link
- Cite
- Citations: 72
Hutchinson M, Sohal M, Layton M, et al., 2019, STEROID-FREE MANAGEMENT OF LIFE-THREATENING HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN THE CONTEXT OF SUSPECTED LYMPHOPROLIFERATIVE DISEASE AND INFECTION, Annual Conference of the British-Soceity-for-Rheumatology, Publisher: OXFORD UNIV PRESS, ISSN: 1462-0324
Thielemans L, Layton DM, Shovlin CL, 2019, Low serum haptoglobin and blood films suggest intravascular haemolysis contributes to severe anaemia in hereditary haemorrhagic telangiectasia, Haematologica, Vol: 104, Pages: e127-e130, ISSN: 0390-6078
Brierley C, Babbs C, McGowan S, et al., 2019, Whole genome sequencing for the investigation of rare anaemias: Challenges and real-world outcomes, 59th Annual Scientific Meeting of the British-Society-for-Hematology, Publisher: WILEY, Pages: 115-116, ISSN: 0007-1048
Grace RF, Layton DM, Barcellini W, 2019, How we manage patients with pyruvate kinase deficiency, BRITISH JOURNAL OF HAEMATOLOGY, Vol: 184, Pages: 721-734, ISSN: 0007-1048
- Author Web Link
- Cite
- Citations: 48
Vora SM, Proven M, Hipkiss R, et al., 2019, Glucophosphate isomerase deficiency identified by next-generation sequencing, 59th Annual Scientific Meeting of the British-Society-for-Hematology, Publisher: WILEY, Pages: 118-118, ISSN: 0007-1048
Thielemans L, Layton M, Shovlin CL, 2018, EVIDENCE OF HAEMOLYSIS IN PATIENTS WITH PULMONARY AVMS AND HEREDITARY HAEMORRHAGIC TELANGIECTASIA, Winter Meeting of the British-Thoracic-Society, Publisher: BMJ PUBLISHING GROUP, Pages: A102-A103, ISSN: 0040-6376
Lucchini E, Luqmani A, Atta M, et al., 2018, Autoimmune Cytopenias Following Alemtuzumab-Induced Renal Transplant: Clinical Features and Treatment Outcomes, 60th Annual Meeting of the American-Society-of-Hematology (ASH), Publisher: AMER SOC HEMATOLOGY, ISSN: 0006-4971
Griffin M, Neilly I, Nikolousis M, et al., 2018, Lessons learned from a review of paroxysmal nocturnal haemoglobinuria (PNH) requests: a report from the UK PNH Network, BRITISH JOURNAL OF HAEMATOLOGY, Vol: 182, Pages: 930-933, ISSN: 0007-1048
- Author Web Link
- Cite
- Citations: 2
Hanina S, Bain BJ, Clark B, et al., 2018, Congenital sideroblastic anemia in a female, AMERICAN JOURNAL OF HEMATOLOGY, Vol: 93, Pages: 1181-1182, ISSN: 0361-8609
- Author Web Link
- Cite
- Citations: 1
Spencer-Chapman M, Luqmani A, Layton DM, et al., 2018, Unusual inclusions in hemoglobin H disease post-splenectomy, AMERICAN JOURNAL OF HEMATOLOGY, Vol: 93, Pages: 963-964, ISSN: 0361-8609
Stotesbury H, Kirkham FJ, Kolbel M, et al., 2018, White matter integrity and processing speed in sickle cell anemia, NEUROLOGY, Vol: 90, Pages: E2042-E2050, ISSN: 0028-3878
- Author Web Link
- Cite
- Citations: 51
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.